Axim Biotechnologies has initiated a clinical trial of its non-prescription hemp-derived cannabinoid functional chewing gum for the treatment of patients with irritable bowel syndrome.

Cannabidiol (CBD) has been “shown to have promising effects, but there has been a clear need for practical and effective formulations,” Renger Witkamp, PhD, professor and chair of nutrition and pharmacology at Wageningen University, said in a press release.

“Providing it via a chewing gum results in sustained release of the compound and better bio-availability.”

Click here to read the complete article

Healio.com ~

Recent News Articles

Monday June 24

Could CBD Fight Superbugs? Marijuana Compound Shows Promise As an Antibiotic - Cannabis News

in Medical News

by Bruce Kennedy - Editor in Chief

The quest for new antibiotics has led researchers to a surprising candidate: the marijuana compound…

261 hits

Monday June 24

Cannabis Brands Need to Establish a Purpose That Doesn’t Rely on Marijuana Puns - Cannabis…

in Finance

by Bruce Kennedy - Editor in Chief

Most have no brand relevancy or purpose and are woefully inept at creating brand experience.

286 hits

Monday June 24

Japanese students more open to use of marijuana, survey suggests - Cannabis News

in World News

by Bruce Kennedy - Editor in Chief

Japanese junior high school students have become more open to the use of marijuana, in…

263 hits

Monday June 24

South Carolina hemp farming could top 3,000 acres as states scramble for a piece of…

in Cannabis News

by Bruce Kennedy - Editor in Chief

In just its second year growing hemp, South Carolina is projecting a 1,200% increase in…

665 hits

Tuesday June 25

Illinois becomes 11th state to allow recreational marijuana - Cannabis News

in Top Stories

by Bruce Kennedy - Editor in Chief

Illinois’ new governor delivered on a top campaign promise Tuesday by signing legislation legalizing small…

547 hits